✦ LIBER ✦

592 POSTER Obatoclax (GX17–070), a small molecule pan-bcl-2 inhibitor, in combination with docetaxel in a phase I/II trial enrolling patients with relapsed non-small cell lung cancer (NSCLC)

✍ Scribed by A. Chiappori; C. Williams; D. Northfelt; J. Adams; S. Malik; M. Edelman; P. Rosen; D. Van Echo; M. Berger; E. Haura

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of the combination taxot

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB

A phase I–II study of docetaxel (D) and

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

52 Milti-institutional phase II trial of

✍ Belani, C.P.; Einzig, A.; Bonomi, P.; Dobbs, T.; Kozak, C.; Cohen, L.; Capozzoli 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB

1084 Interim results of a phase II trial

✍ Zalcberg, J.R.; Bishop, J.F.; Millward, M.J.; Zimet, A.; Laird, J.; Barter, C.; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Cisplatin and gemcitabine combined with

✍ R. Zinner; B. Glisson; K. Pisters; F. Khuri; Y. Oh; J. Ro; N. Ordonez; A. El-Nag 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 140 KB

9117 POSTER Randomized Phase II Trial of

✍ Hirai, F.; Murakami, H.; Yamamoto, N.; Yamanaka, T.; Okamoto, I.; Sawa, T.; Hira 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB